Literature DB >> 2302076

Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.

L Nilsson1, K E Storm, S Thelin, L Bagge, J Hultman, J Thorelius, U Nilsson.   

Abstract

Complement activation was studied during cardiopulmonary bypass (CPB) in the pig. One group of animals was perfused for 2 h using a standard extracorporeal circuit including a hollow fiber membrane oxygenator with full systemic heparinization. Another group was treated in the same way, except that bypass was performed through a heparin-coated CPB circuit (Carmeda Bio-Active Surface, CBAS) and systemic heparinization was reduced by 75%. It was found that complement activation during CPB, measured as changes in the ratio C3d/C3, was significantly less in the CBAS group, most probably reflecting a better biocompatibility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302076     DOI: 10.1111/j.1525-1594.1990.tb01591.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  5 in total

1.  Blood and Blood Product Conservation: Results of Strategies to Improve Clinical Outcomes in Open Heart Surgery Patients at a Tertiary Hospital.

Authors:  Junaid H Khan; Emily A Green; Jimmin Chang; Alexandria M Ayala; Marilyn S Barkin; Emily E Reinys; Jeffrey Stanton; Russell D Stanten
Journal:  J Extra Corpor Technol       Date:  2017-12

2.  Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?

Authors:  B E Steinbrueckner; U Steigerwald; F Keller; K Neukam; O Elert; J Babin-Ebell
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

3.  Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model.

Authors:  J Gong; R Larsson; K N Ekdahl; T E Mollnes; U Nilsson; B Nilsson
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

4.  A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling.

Authors:  Daniel C Leslie; Anna Waterhouse; Julia B Berthet; Thomas M Valentin; Alexander L Watters; Abhishek Jain; Philseok Kim; Benjamin D Hatton; Arthur Nedder; Kathryn Donovan; Elana H Super; Caitlin Howell; Christopher P Johnson; Thy L Vu; Dana E Bolgen; Sami Rifai; Anne R Hansen; Michael Aizenberg; Michael Super; Joanna Aizenberg; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-10-12       Impact factor: 54.908

5.  The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent.

Authors:  K T Lappegård; G Bergseth; J Riesenfeld; A Pharo; P Magotti; J D Lambris; T E Mollnes
Journal:  J Biomed Mater Res A       Date:  2008-10       Impact factor: 4.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.